| AVANX | SFILX | AVANX / SFILX | |
| Total Expense Ratio | 0.00 | 0.39 | - |
| Annual Report Gross Expense Ratio | 0.36 | 0.39 | 92% |
| Fund Existence | 5 years | 18 years | - |
| Gain YTD | 9.046 | 6.917 | 131% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 604M | 702M | 86% |
| Annual Yield % from dividends | 3.52 | 3.44 | 102% |
| Returns for 1 year | 43.18 | 36.66 | 118% |
| Returns for 3 years | 73.70 | 49.34 | 149% |
| Returns for 5 years | 84.38 | 33.96 | 248% |
| Returns for 10 years | N/A | 95.76 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMDM | 36.46 | 0.67 | +1.87% |
| First Trust Bloomberg Emr Mkt Dem ETF | |||
| VFL | 10.39 | 0.06 | +0.58% |
| abrdn National Municipal Income Fund | |||
| GXUS | 59.25 | 0.11 | +0.19% |
| Goldman Sachs MarketBeta(R) Ttl IntEqETF | |||
| GENM | 10.37 | 0.02 | +0.14% |
| Genter Capital Municipal Qual Interm ETF | |||
| IBB | 173.80 | -0.34 | -0.20% |
| iShares Biotechnology ETF | |||